![Sohanya Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sohanya Cheng
Corporate Officer/Principal at
KARYOPHARM THERAPEUTICS INC.
Net worth: 729 725 $ as of 30/01/2026
Profile
Sohanya Cheng is currently Chief Commercial Officer at Karyopharm Therapeutics, Inc. since 2021.
Former roles include Executive Director & Head-National Sales Force at Amgen, Inc. from 2019 to 2020, Independent Director at Carisma Therapeutics, Inc. from 2024 to 2025, and VP, Head-Marketing & Corporate Affairs at Arrowhead Pharmaceuticals, Inc. in 2020.
Education includes undergraduate and graduate degrees from the University of Cambridge and an MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/01/2026 | 111,921 ( 0.61% ) | 729 725 $ | 30/01/2026 | |
| 30/05/2025 | 0 ( -.--% ) | - $ | 30/01/2026 |
Sohanya Cheng active positions
| Companies | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 09/01/2022 |
Former positions of Sohanya Cheng
| Companies | Position | End |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director/Board Member | 30/12/2025 |
| ARROWHEAD PHARMACEUTICALS, INC. | Sales & Marketing | 30/11/2020 |
| AMGEN INC. | Sales & Marketing | 31/07/2020 |
Training of Sohanya Cheng
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
- Stock Market
- Insiders
- Sohanya Cheng
